Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 May;51(5):671–672. doi: 10.1136/ard.51.5.671

Antiphospholipid antibodies in homozygous sickle cell disease.

K De Ceulaer 1, M A Khamashta 1, E N Harris 1, G R Serjeant 1, G R Hughes 1
PMCID: PMC1005705  PMID: 1616337

Abstract

Serum samples from 108 unselected Jamaican patients with homozygous sickle cell disease and 116 control subjects with normal haemoglobin were screened for the presence of antiphospholipid antibodies. Slightly increased levels of IgG antiphospholipid antibodies were found in nine patients with sickle cell disease and in none of the control subjects. Serial control samples confirmed the increased levels of antiphospholipid antibodies. A comparison of the haematological and clinical features of patients with positive and negative antiphospholipid sickle cell disease did not highlight any differences between the groups.

Full text

PDF
671

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Asherson R. A., Harris E. N. Anticardiolipin antibodies--clinical associations. Postgrad Med J. 1986 Dec;62(734):1081–1087. doi: 10.1136/pgmj.62.734.1081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohen P., Derksen A. Comparison of phospholipid and fatty acid composition of human erythrocytes and platelets. Br J Haematol. 1969 Oct;17(4):359–371. doi: 10.1111/j.1365-2141.1969.tb01382.x. [DOI] [PubMed] [Google Scholar]
  3. Gharavi A. E., Harris E. N., Asherson R. A., Hughes G. R. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 1987 Jan;46(1):1–6. doi: 10.1136/ard.46.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harris E. N., Gharavi A. E., Hughes G. R. Anti-phospholipid antibodies. Clin Rheum Dis. 1985 Dec;11(3):591–609. [PubMed] [Google Scholar]
  5. Hernandez D. E., Gonzalez N., Rios R., Merchan L., Wuani H. Phagocytosis in patients with sickle cell disease. J Clin Lab Immunol. 1983 Nov;12(3):137–140. [PubMed] [Google Scholar]
  6. Hughes G. R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed) 1983 Oct 15;287(6399):1088–1089. doi: 10.1136/bmj.287.6399.1088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Khamashta M. A., Harris E. N., Gharavi A. E., Derue G., Gil A., Vázquez J. J., Hughes G. R. Immune mediated mechanism for thrombosis: antiphospholipid antibody binding to platelet membranes. Ann Rheum Dis. 1988 Oct;47(10):849–854. doi: 10.1136/ard.47.10.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Levine S. R., Diaczok I. M., Deegan M. J., Kieran S. N., Feit H., Elias S. B., Welch K. M. Recurrent stroke associated with thymoma and anticardiolipin antibodies. Arch Neurol. 1987 Jun;44(6):678–679. doi: 10.1001/archneur.1987.00520180090026. [DOI] [PubMed] [Google Scholar]
  9. Lubin B., Chiu D., Bastacky J., Roelofsen B., Van Deenen L. L. Abnormalities in membrane phospholipid organization in sickled erythrocytes. J Clin Invest. 1981 Jun;67(6):1643–1649. doi: 10.1172/JCI110200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Millard D., De Ceulaer K., Vaidya S., Serjeant G. R. Serum immunoglobulin levels in children with homozygous sickle cell disease. Clin Chim Acta. 1982 Oct 13;125(1):81–87. doi: 10.1016/0009-8981(82)90048-1. [DOI] [PubMed] [Google Scholar]
  11. Milner P. F., Jones B. R., Döbler J. Outcome of pregnancy in sickle cell anemia and sickle cell-hemoglobin C disease. An analysis of 181 pregnancies in 98 patients, and a review of the literature. Am J Obstet Gynecol. 1980 Oct 1;138(3):239–245. doi: 10.1016/0002-9378(80)90241-0. [DOI] [PubMed] [Google Scholar]
  12. Pearson H. A., Spencer R. P., Cornelius E. A. Functional asplenia in sickle-cell anemia. N Engl J Med. 1969 Oct 23;281(17):923–926. doi: 10.1056/NEJM196910232811703. [DOI] [PubMed] [Google Scholar]
  13. Portnoy B. A., Herion J. C. Neurological manifestations in sickle-cell disease, with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med. 1972 Apr;76(4):643–652. doi: 10.7326/0003-4819-76-4-643. [DOI] [PubMed] [Google Scholar]
  14. Powars D., Wilson B., Imbus C., Pegelow C., Allen J. The natural history of stroke in sickle cell disease. Am J Med. 1978 Sep;65(3):461–471. doi: 10.1016/0002-9343(78)90772-6. [DOI] [PubMed] [Google Scholar]
  15. Schleider M. A., Nachman R. L., Jaffe E. A., Coleman M. A clinical study of the lupus anticoagulant. Blood. 1976 Oct;48(4):499–509. [PubMed] [Google Scholar]
  16. Wilson W. A., Nicholson G. D., Hughes G. R., Amin S., Alleyne G., Serjeant G. R. Systemic lupus erythematosus and sickle-cell anaemia. Br Med J. 1976 Apr 3;1(6013):813–813. doi: 10.1136/bmj.1.6013.813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zarrabi M. H., Zucker S., Miller F., Derman R. M., Romano G. S., Hartnett J. A., Varma A. O. Immunologic and coagulation disorders in chlorpromazine-treated patients. Ann Intern Med. 1979 Aug;91(2):194–199. doi: 10.7326/0003-4819-91-2-194. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES